QUIK:NASDAQQuickLogic Corporation Analysis
Data as of 2026-07-16 - not real-time
$14.17
Latest Price
8/10Risk
Risk Level: High
Executive Summary
QuickLogic (QUIK) is trading at $14.17, well below its 20‑day (≈$17.8) and 50‑day (≈$19.4) moving averages, with an RSI around 34 and a bearish MACD crossover, signaling short‑term weakness. Volume is slipping and the stock’s beta of roughly 2.7 together with a 30‑day volatility exceeding 100% point to a highly volatile profile.
Fundamentally, the company posts modest revenue growth (~17%) but suffers deep operating losses (‑42% margin) and a trailing EPS of –$0.75. Valuation metrics are starkly out of line – a forward P/E of 103 versus an industry average of 34, a price‑to‑book above 10, and a DCF‑derived fair value near $2.30 – indicating the stock is severely overvalued. The balance sheet shows a high debt‑to‑equity ratio (≈14) and no dividend, while the only material news is a conference appearance, offering little near‑term catalyst.
Fundamentally, the company posts modest revenue growth (~17%) but suffers deep operating losses (‑42% margin) and a trailing EPS of –$0.75. Valuation metrics are starkly out of line – a forward P/E of 103 versus an industry average of 34, a price‑to‑book above 10, and a DCF‑derived fair value near $2.30 – indicating the stock is severely overvalued. The balance sheet shows a high debt‑to‑equity ratio (≈14) and no dividend, while the only material news is a conference appearance, offering little near‑term catalyst.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below key moving averages and bearish MACD
- RSI in oversold territory with high volatility
- Severe overvaluation relative to DCF and industry peers
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue growth continues but margins remain negative
- Positive free cash flow provides a modest cushion
- Lack of concrete catalysts beyond conference participation
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Potential upside if the company can turn operating cash flow positive
- High beta and sector cyclicality keep risk elevated
- Current valuation leaves limited room for price appreciation
Key Metrics & Analysis
Financial Health
Revenue Growth16.80%
Profit Margin-102.28%
P/E Ratio103.1
ROE-49.23%
ROA-17.99%
Debt/Equity14.36
P/B Ratio10.4
Op. Cash Flow$-415000
Free Cash Flow$1.5M
Industry P/E34.0
Technical Analysis
TrendNeutral
RSI34.6
Support$13.66
Resistance$22.50
MA 20$17.76
MA 50$19.36
MA 200$10.84
MACDBearish
VolumeDecreasing
Fear & Greed Index92.45
Valuation
Fair Value$2.33
Target Price$23.67
Upside/Downside67.02%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.70
Volatility101.70%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.